Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022

SELL
$5.87 - $13.13 $89,957 - $201,217
-15,325 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$12.15 - $17.4 $186,198 - $266,655
15,325 New
15,325 $196,000
Q2 2020

Jul 28, 2020

SELL
$2.87 - $5.83 $490,391 - $996,160
-170,868 Closed
0 $0
Q1 2020

Apr 21, 2020

BUY
$3.24 - $8.51 $30,650 - $80,504
9,460 Added 5.86%
170,868 $613,000
Q4 2019

Feb 12, 2020

SELL
$6.29 - $8.46 $29,122 - $39,169
-4,630 Reduced 2.79%
161,408 $1.37 Million
Q3 2019

Nov 07, 2019

BUY
$6.3 - $7.9 $55,125 - $69,125
8,750 Added 5.56%
166,038 $1.12 Million
Q2 2019

Aug 06, 2019

BUY
$3.64 - $6.95 $91,000 - $173,750
25,000 Added 18.9%
157,288 $1.06 Million
Q1 2019

May 06, 2019

BUY
$6.31 - $8.75 $834,737 - $1.16 Million
132,288 New
132,288 $835,000

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $52.6M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.